期刊文献+

左乙拉西坦治疗96例儿童癫痫的临床疗效分析 被引量:16

The clinical effect of Levetiracetam on 96 children patients with epilepsy
下载PDF
导出
摘要 目的探讨左乙拉西坦治疗儿童癫痫的疗效和安全性。方法对我院96例儿童癫痫患者采用左乙拉西坦单药治疗,进行随访,观察其发作次数及不良反应。结果 96例癫痫患者中,68例患者发作控制,14例患者显效,9例患者无效,5例患者加重,总有效率85.4%;不同类型癫痫有效率的比较,差异无统计学意义(P>0.05)。不同类型癫痫治疗前后发作次数均有明显减少,治疗前后发作次数比较,差异有统计学意义(P<0.05);18例患者治疗后出现副反应(发生率为19%),主要表现为嗜睡、头晕及记忆力下降等,对症治疗或达到维持剂量后自行消失。结论左乙拉西坦单药治疗儿童癫痫具有良好的疗效及安全性。 Objective To study the clinical effect and safety of Levetiracetam treatment on epilepsy. Methods All of 96 children patients with epilepsy were treated by Levetiracetam,then follow-up visited,its effect and severe adverse effects were evaluated. Results All of 96 patients completed this study,68 children seizure-free, 14 children controlled 9 children no effect and 5 child aggravated, the total efficiency was 85.4%. No significant difference of the total efficiency was found between different kinds of epilepsy. However,the difference of attacking times among all kinds of groups were siginificant. 18 children had severe adverse effects, which characterized as drowsiness ,dizziness, memory deterioration and so on.These syndromes were disappeared after treatment or reaching the full dose. Conclusion Levetiracetam has good effect and safety on epilepsy.
作者 扶杨
出处 《中国现代医生》 2012年第10期66-67,共2页 China Modern Doctor
关键词 左乙拉西坦 癫痫 临床疗效 发作 不良反应 Levetiracetam Epilepsy Clinical effects Attacking Severe adverse effects
  • 引文网络
  • 相关文献

参考文献8

  • 1Steinhoff BJ,Trinka E,wieser HG. Levetiraeetam in patients with refrac- tory epilepsy:Results of the SKATE trial in Austria,Germany anti switzerland[J]. Seizure,2005,14(7) :490-496.
  • 2肖斌.丙戊酸钠与左乙拉西坦治疗小儿癫痫60例疗效分析[J].中国民族民间医药,2010,19(12):9-10. 被引量:13
  • 3丁庆明,任连坤.抗癫痫新药左乙拉西坦的临床应用和安全性[J].药物不良反应杂志,2007,9(4):295-301. 被引量:40
  • 4王学禹,李明霞.左乙拉西坦在癫痫治疗中的应用进展[J].山东医药,2008,48(11):110-111. 被引量:27
  • 5Carunehio I,Pieri M,Clotti MT. Modulation of AMPA receptorsiu cul- tured cortical neurons induced by the antiepileptic drug levetiracetam[J]. Epilepsia, 2007,48 (4) : 654-662.
  • 6Hirsch J,Arif H,Buchsbaum R. Effect of age and comedication on leve- tiracetam pharmacokinetics and tolerability[J]. Epilepsia,2007,48 (7): 1351-1359.
  • 7Sharpe DV,Patela D,Aboukhalil B. leveetiracetam monotherapy in ju- venile rnyoclonic epilepsy[J]. Seizure, 2008,17 ( 1 ) : 64-68.
  • 8White JR,Walczak TS,leppik IE. Discontinuation of levetiraeetam be- cause of behavioral side effects : a case-control study[J]. Neurology, 2003, 61 (9) : 1218-1221.

二级参考文献51

共引文献72

同被引文献99

  • 1肖波,刘献增,龙小艳,等.癫痫治疗学[M].北京.人民卫生出版社,2010:163-170.
  • 2丁庆明,任连坤.抗癫痫新药左乙拉西坦的临床应用和安全性[J].药物不良反应杂志,2007,9(4):295-301. 被引量:40
  • 3Major P,Thiele EA. Seizures in children:determining the variation[J].{H}Pediatrics in Review,2007,(10):363-371.
  • 4Corey LA,Pellock JM,Kjeldsen MJ. Importance of genetic factors in the occurrence of epilepsy syndrome type:a twin study[J].{H}Epilepsy Research,2011,(01):287-293.
  • 5Stasiukyniene V,Pilvinis V,Reingardiene D. Epileptic seizures in critically ill patients[J].{H}Medicina(Kaunas),2009,(06):501-507.
  • 6Moser SJ,Weber P,Ltütschg J. Rett syndrome:clinical and electrophysiologic aspects[J].{H}Pediatric Neurology,2007,(02):95-100.
  • 7Walker M C. Diagnosis and treatment of nonconvulsive status epilepticus [ J ]. CNS Drugs, 2001,15 ( 12 ) : 931- 939.
  • 8Visweswari G, Siva P K, Lokanatha V, et al. The antiep- ileptic effect of centella asiatica on the activities of Na ~/ K ~ , Mg2~ and Ca2~ -ATPases in rat brain during pentyle- netetrazol-induced epilepsy ~ J ]. Indian J Pharmacol, 2010,42(2) :82-86.
  • 9Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of p-glycoprotein and multidrug re- sistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis [ J ]. Epilepsy Res, 2006,68 ( 3 ) : 213-228.
  • 10Furuno T, Landi M T, Ceroni M, et al. Expression poly- morphism of the blood-brain barrier component p-glyco- protein (mdrl) in relation to parkinson ~s disease [ J ]. Pharmacogenetics, 2002,12 ( 7 ) :529-534.

引证文献16

二级引证文献106

;
使用帮助 返回顶部